Relay Therapeutics, Inc. (RLAY) — 10-Q Filings

10-Q Filings (6)

• Relay Therapeutics Narrows Q3 Loss Amid R&D Cuts — Nov 6, 2025 Risk: high
  Relay Therapeutics, Inc. reported a net loss of $74.1 million for the three months ended September 30, 2025, an improvement from the $88.1 million net loss in t
• Relay Therapeutics' Q2 Net Loss Widens to $90.9M Amid R&D Surge — Aug 7, 2025 Risk: high
  Relay Therapeutics, Inc. reported a net loss of $90.9 million for the quarter ended June 30, 2025, a significant increase from the $79.9 million net loss in the
• Relay Therapeutics Files Q1 2025 10-Q — May 5, 2025 Risk: low
  Relay Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported its financial position and operational highlights. Key financ
• Relay Therapeutics Files Q3 2024 10-Q — Nov 6, 2024 Risk: medium
  Relay Therapeutics, Inc. filed its 10-Q for the period ending September 30, 2024. The company, headquartered at 399 Binney Street, Cambridge, MA, reported on it
• Relay Therapeutics Files Q2 2024 10-Q — Aug 6, 2024 Risk: medium
  Relay Therapeutics, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported its financial results and provided updates on its business ope
• Relay Therapeutics, Inc. Files 10-Q for Q1 2024 — May 2, 2024 Risk: low
  Relay Therapeutics, Inc. (RLAY) filed a Quarterly Report (10-Q) with the SEC on May 2, 2024. Relay Therapeutics, Inc. filed a 10-Q for the period ending March 3

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX